chrX-150462831-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_005491.5(MAMLD1):āc.156A>Gā(p.Pro52=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00262 in 1,206,952 control chromosomes in the GnomAD database, including 47 homozygotes. There are 825 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.013 ( 17 hom., 370 hem., cov: 23)
Exomes š: 0.0016 ( 30 hom. 455 hem. )
Consequence
MAMLD1
NM_005491.5 synonymous
NM_005491.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.138
Genes affected
MAMLD1 (HGNC:2568): (mastermind like domain containing 1) This gene encodes a mastermind-like domain containing protein. This protein may function as a transcriptional co-activator. Mutations in this gene are the cause of X-linked hypospadias type 2. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Apr 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant X-150462831-A-G is Benign according to our data. Variant chrX-150462831-A-G is described in ClinVar as [Benign]. Clinvar id is 714971.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.138 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0129 (1450/112309) while in subpopulation AFR AF= 0.0439 (1354/30874). AF 95% confidence interval is 0.0419. There are 17 homozygotes in gnomad4. There are 370 alleles in male gnomad4 subpopulation. Median coverage is 23. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 17 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MAMLD1 | NM_005491.5 | c.156A>G | p.Pro52= | synonymous_variant | 3/8 | ENST00000370401.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MAMLD1 | ENST00000370401.7 | c.156A>G | p.Pro52= | synonymous_variant | 3/8 | 5 | NM_005491.5 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0129 AC: 1453AN: 112255Hom.: 17 Cov.: 23 AF XY: 0.0108 AC XY: 371AN XY: 34411
GnomAD3 genomes
AF:
AC:
1453
AN:
112255
Hom.:
Cov.:
23
AF XY:
AC XY:
371
AN XY:
34411
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00392 AC: 711AN: 181375Hom.: 18 AF XY: 0.00227 AC XY: 153AN XY: 67257
GnomAD3 exomes
AF:
AC:
711
AN:
181375
Hom.:
AF XY:
AC XY:
153
AN XY:
67257
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00156 AC: 1712AN: 1094643Hom.: 30 Cov.: 29 AF XY: 0.00126 AC XY: 455AN XY: 360091
GnomAD4 exome
AF:
AC:
1712
AN:
1094643
Hom.:
Cov.:
29
AF XY:
AC XY:
455
AN XY:
360091
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0129 AC: 1450AN: 112309Hom.: 17 Cov.: 23 AF XY: 0.0107 AC XY: 370AN XY: 34475
GnomAD4 genome
AF:
AC:
1450
AN:
112309
Hom.:
Cov.:
23
AF XY:
AC XY:
370
AN XY:
34475
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 25, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at